HOME >> BIOLOGY >> NEWS
Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer

The number of lymph nodes that contain evidence of cancer is the best predictor of the effectiveness of adding chemotherapy and radiation to a treatment plan prior to surgery in individuals with oesophageal cancer, according to a study published last month in the Annals of Surgery. The authors say their finding is particularly important because the focus of recent pathological studies of response to neoadjuvant therapies has been on the primary tumour rather than nodal sites.

Multimodal neoadjuvant therapy---where suitable patients are given several cycles of drugs and radiation therapy before undergoing surgical procedures to remove their tumour---is increasingly being used by oncologists as a way to boost survival rates from oesophageal cancer which, even with the most radical surgery, remain low: only 50% of patients survive for 3 years. However, the evidence for which additional therapies work best is confusing and conflicting. What is more, although it is widely accepted that there is a group of patients in whom this approach works well, identifying who these patients are is no easy task.

To help find ways of pinpointing individuals who might respond best to neoadjuvant treatment, John Vincent Reynolds and colleagues followed the progress of 243 patients who were treated with chemotherapy and radiation before surgery over 5 years. They paid particular attention to the histomorphological responses of patients---changes in the structure and appearance of tissue samples when viewed under a microscope---in addition to assessing prognosis using the traditional TNM method of staging, which takes into account tumour size, involvement of lymph nodes (nodal status), and presence or absence of metastases.

The study group consisted of all patients undergoing neoadjuvant treatment for oesophageal cancer at St James Hospital in Dublin,Ireland. Patients with oesophageal cancer were deemed suitable for multimodal therapy if they fulfilled
'"/>

Contact: Corinne Hall
mediaservice@esoncology.org
39-028-546-4522
European School of Oncology
13-Jul-2007


Page: 1 2 3

Related biology news :

1. MU researchers to study the status of black bears in Missouri
2. Green sturgeon receives threatened status
3. High-status monkeys ignore the interests of riff-raff
4. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible status
5. Sudden change in social status triggers genetic response in male fish, study finds
6. Manatee eyes could be window to health status
7. Location, location, location: Effect of nuclear organization on transcriptional status
8. Biologists findings on fertility and status in monkeys generate scientific, media interest
9. MIDI, Inc receives Official Methods(SM) status for the confirmatory ID of the anthrax pathogen
10. Study in Royal Society journal on how relationship status influences sex ratios
11. DNA highly promising predictor for successful treatment of alcoholics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... , ... November 12, 2019 , ... ... of orthopedic medical devices, today announced the creation of a Global Regulatory Affairs ... the Medical Device industry is that the regulatory element to any Medtech organization ...
(Date:11/12/2019)... BEND, Ore. (PRWEB) , ... November 12, 2019 ... ... is launching Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% ... Smart Digital Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict ...
(Date:11/12/2019)... ... 12, 2019 , ... Atlantic Ultraviolet Corporation (AUV), the premier ... voted their patented automatic and manual wipers the #1 best feature of the ... maintenance task required of an ultraviolet water purifier is quartz sleeve cleaning. A ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... 12, 2019 , ... Peggy Lillis Foundation (PLF) has launched ... infection C. diff. The campaign, “See C. diff,” combines basic facts ... 30,000 people in the U.S. each year. The campaign also features a portrait ...
(Date:11/5/2019)... (PRWEB) , ... November 05, 2019 , ... ... technology, announced it has received CE Mark for its Fusion Bx 2.0 prostate ... arm and user-friendly interface, the Fusion Bx 2.0 will give urologists across Europe ...
(Date:10/30/2019)... S.D. (PRWEB) , ... October 30, 2019 , ... While ... of researchers and students at South Dakota School of Mines & Technology ... cells while leaving healthy cells alive. , If successful, the technique would prove ...
(Date:10/26/2019)... ... October 24, 2019 , ... Sparks Marketing Group, ... (BMMG), a boutique healthcare-specific marketing firm, to strengthen the agency’s growing focus ... Division. , Healthcare clients in pharma, bio-therapeutics, medical device and healthcare technologies currently ...
Breaking Biology Technology:
Cached News: